Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Index
RUT
Market Cap
583.10M
Enterprise Value
725.00M
Income
6.71M
Sales
249.13M
Book/sh
33.71
Cash/sh
4.87
Employees
717
IPO
Feb 29, 1984
P/E
87.40
Forward P/E
8.54
PEG
-
P/S
2.34
P/B
3.13
P/C
21.65
P/FCF
14.73
EV/EBITDA
17.35
EV/Sales
2.91
Quick Ratio
1.29
Current Ratio
1.72
Debt/Eq
0.91
LT Debt/Eq
0.86
Option/Short
No / Yes
EPS (ttm)
1.21
EPS next Y
12.36
EPS next Q
2.62
EPS this Y
3.24%
EPS next Y
4.92%
EPS next 5Y
-
EPS past 3/5Y
90.85% 13.55%
Sales past 3/5Y
4.38% 13.22%
EPS Y/Y TTM
445.05%
Sales Y/Y TTM
3.38%
EPS Q/Q
42.97%
Sales Q/Q
2.56%
Insider Own
3.42%
Insider Trans
-1.13%
Inst Own
87.71%
Inst Trans
1.25%
ROA
1.56%
ROE
3.88%
ROIC
1.94%
Gross Margin
56.56%
Oper. Margin
7.43%
Profit Margin
2.69%
SMA20
3.80%
SMA50
3.56%
SMA200
21.89%
Trades
Shs Outstand
5.52M
Shs Float
5.34M
52W High
113.99 -7.41%
52W Low
55.45 90.33%
Volatility
5.15% 5.51%
ATR (14)
5.71
RSI (14)
56.31
Beta
0.91
Rel Volume
0.68
Avg Volume
173.56K
Volume
117,356
Perf Week
7.53%
Perf Month
-1.05%
Perf Quarter
19.31%
Perf Half Y
34.27%
Perf YTD
34.45%
Perf Year
4.88%
Perf 3Y
-17.87%
Perf 5Y
-61.15%
Perf 10Y
-15.56%
Prev Close
104.39
Price
105.54
Change
1.10%
Date Action Analyst Rating Change Price Target Change
Aug-07-25Upgrade Wells Fargo Underweight → Equal Weight $67
Aug-28-24Initiated Wells Fargo Underweight $120
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Jun-17-26 04:42AM
May-27-26 08:18AM
08:00AM
May-05-26 01:39PM
Apr-02-26 06:00PM
04:30PM Loading…
Mar-09-26 04:30PM
Feb-20-26 07:02AM
Feb-03-26 08:11AM
08:00AM
Jan-07-26 05:00PM
Dec-18-25 07:00PM
Dec-03-25 05:35PM
Nov-25-25 08:09AM
Nov-12-25 03:14PM
Nov-06-25 07:01PM
04:15PM Loading…
04:15PM
Oct-03-25 11:46AM
11:01AM
Sep-22-25 06:53AM
Sep-05-25 06:34PM
Aug-18-25 02:01PM
Aug-05-25 09:15AM
08:10AM
08:00AM
Jul-31-25 05:45PM
Jul-03-25 12:00PM
Jul-02-25 03:20PM
May-28-25 09:15AM
08:23AM
08:00AM
05:25PM Loading…
May-15-25 05:25PM
May-14-25 05:45PM
May-13-25 05:35PM
May-08-25 08:45AM
Apr-07-25 03:00PM
Apr-03-25 03:51PM
Mar-26-25 12:00PM
Feb-13-25 08:31AM
Feb-11-25 12:20PM
Feb-04-25 09:15AM
08:17AM
08:00AM
Jan-17-25 01:15PM
Jan-06-25 03:00PM
Nov-07-24 09:20AM
08:27AM
08:00AM
Oct-15-24 05:02PM
Oct-02-24 02:00PM
Aug-26-24 12:20PM
12:00PM
Aug-16-24 07:51AM
Aug-05-24 08:15AM
08:00AM
Jul-31-24 09:14AM
Jul-08-24 02:00PM
Jun-05-24 11:53AM
06:38AM
06:21AM
06:00AM
May-31-24 06:00AM
May-22-24 06:00AM
Apr-08-24 08:00AM
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
Feb-05-24 09:20AM
08:36AM
08:22AM
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Jun-21-23 08:00PM
11:50AM
May-25-23 09:25AM
08:14AM
08:00AM
May-22-23 01:16PM
May-02-23 06:23AM
Apr-26-23 08:00PM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
VP & CFOMr. John V. Sakys C.P.A.
Senior Vice President of Continuous ImprovementMr. Brian David Archbold
M.S.Dr. Siddhartha Chandrakant Kadia B.E.
Chief Accounting OfficerMs. Lyndsey Crennen
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crennen Lyndsey ElizabethCAOJun 18 '26Option Exercise95.1072669,0432,199Jun 23 01:34 PM
Crennen Lyndsey ElizabethCAOJun 22 '26Sale89.5044239,5602,020Jun 23 01:34 PM
Archbold Brian DavidSVP OperationsJun 18 '26Option Exercise95.103,324316,1127,034Jun 23 01:02 PM
Archbold Brian DavidSVP OperationsJun 22 '26Sale89.502,516225,1876,377Jun 23 01:02 PM
Sakys JohnCFOJun 18 '26Option Exercise95.103,792360,61920,330Jun 23 12:23 PM
Sakys JohnCFOJun 22 '26Sale89.502,827253,02219,785Jun 23 12:23 PM
Sakys JohnOfficerJun 22 '26Proposed Sale89.502,827253,022Jun 22 03:56 PM
Archbold Brian DavidOfficerJun 22 '26Proposed Sale89.502,516225,187Jun 22 03:51 PM
Archbold Brian DavidSVP OperationsJun 16 '26Sale101.271,151116,5583,710Jun 17 12:23 PM
Crennen Lyndsey ElizabethCAOJun 16 '26Sale101.2711811,9501,473Jun 17 12:19 PM
Sakys JohnCFOJun 16 '26Sale101.271,223123,85016,538Jun 17 12:09 PM
Archbold Brian DavidOfficerJun 16 '26Proposed Sale101.271,151116,558Jun 16 03:33 PM
Sakys JohnOfficerJun 16 '26Proposed Sale101.271,223123,850Jun 16 03:31 PM
Owens Gary MFormer OfficerJun 16 '26Proposed Sale101.273,706375,296Jun 16 03:29 PM
Archbold Brian DavidSVP OperationsJun 15 '26Option Exercise104.082,454255,4124,861Jun 16 02:44 PM
Sakys JohnCFOJun 15 '26Option Exercise104.082,717282,78517,761Jun 16 02:15 PM
Ladiwala Shiraz ShabanaliDirectorMar 10 '26Buy72.233,500252,8058,523Mar 10 05:43 PM
Capone Mark ChristopherDirectorMar 10 '26Buy76.351,30199,3313,429Mar 10 03:46 PM
Tripeny R TonyDirectorMar 10 '26Buy76.001,31599,9405,398Mar 10 03:39 PM
Owens Gary MPresident and CEOOct 27 '25Option Exercise0.0011,558064,135Oct 28 03:08 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '25Option Exercise0.001,94905,023Aug 18 02:37 PM
Sullivan John JamesDirectorAug 15 '25Option Exercise0.001,404027,282Aug 18 02:20 PM
Hall ShannonDirectorAug 15 '25Option Exercise0.001,40404,189Aug 18 02:02 PM
Tripeny R TonyDirectorAug 15 '25Option Exercise0.001,40404,083Aug 18 01:54 PM
Capone Mark ChristopherDirectorAug 15 '25Option Exercise0.001,40402,128Aug 18 01:45 PM
Alltoft Jennifer SadieDirectorAug 15 '25Option Exercise0.001,40404,878Aug 18 01:34 PM